Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review
M Dauvergne, D Buob, C Rafat… - Clinical Kidney …, 2021 - academic.oup.com
Background The spectrum of interferon-β (IFN-β)-associated nephropathy remains poorly
described and the potential features of this uncommon association remain to be determined …
described and the potential features of this uncommon association remain to be determined …
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to …
M Allinovi, T Mazzierli, S Laudicina, L Pastò… - Journal of Clinical …, 2024 - mdpi.com
Thrombotic microangiopathy (TMA) has been observed in some patients receiving interferon
beta (IFNβ) therapy for relapsing-remitting multiple sclerosis, but little is known about its …
beta (IFNβ) therapy for relapsing-remitting multiple sclerosis, but little is known about its …
[PDF][PDF] Renal diseases secondary to interferon-b treatment: a multicentre clinico-pathological study and systematic
M Dauvergne, D Buob, C Rafat, MF Hennino… - hal.sorbonne-universite.fr
Background. The spectrum of interferon-b (IFN-b)-associated nephropathy remains poorly
described and the potential features of this uncommon association remain to be determined …
described and the potential features of this uncommon association remain to be determined …
Interferon therapy: Mechanism of renal thrombotic microangiopathy in multiple sclerosis
M Bahadoram, B Keikhaei… - Revista Colombiana …, 2022 - scielo.org.co
Multiple sclerosis (MS) is a common and chronic autoimmune disorder in the central
nervous system (CNS). It is an inflammatory and neurodegenerative disease, in which the …
nervous system (CNS). It is an inflammatory and neurodegenerative disease, in which the …